If you have chance could you do a list of the stocks that have "blown up" (lost 50% or more) in small-cap biotech due to either a failed trial or failure to get FDA approval or the revelations of SAE's in 2005. NABI, RIGL, PCYC, PTN, AXYX, PARS come to mind right away.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.